Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024. Home is where the heart is ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Amid worsening air quality in the national capital, doctors here said its effect was not only limited to physical health but also extended to cognitive wellbeing, affecting mood and emotional ...

the nasal delivery of these nano-aggregates reduced the number of bacteria in the brain by nearly 1, 000 times more than in untreated mice, ” said the team in the paper, published in the journal ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

Mental health treatment has evolved significantly over the years, offering new hope for individuals dealing with conditions .

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that it will present posters highlighting new ...